In the era of personalized therapies, a precise assessment of biomarkers, both at the protein and gene levels, is crucial for an optimal patient management. 1 This is especially true for breast cancer ...

In a molecular diagnostic laboratory, having a system for tracking specimens, or assays, is integral to workflow efficiency and accuracy. Although streamlining this process often proves to be ...

Up to 70 percent of errors associated with lab results happen way before the tests are even analyzed, according to a report from ECRI Institute’s Patient Safety Organization. Getting a delayed ...

Biomarker testing has the potential to streamline diagnosis, treatment planning, and anticipation of treatment risks, if done right.